Eric J. Forman, MD, FACOG discuses the Blastocyst Euploid Selective Transfer (BEST) Trial carried out by Reproductive Medicine Associates of New Jersey.
Eric J. Forman, MD, FACOG discuses the Blastocyst Euploid Selective Transfer (BEST) Trial carried out by Reproductive Medicine Associates of New Jersey.
Model estimates the optimal number of oocytes for ART treatment
March 15th 2023A model to estimate the optimal number of oocytes to try to fertilize during assisted reproductive technology (ART) treatment predicted that 43.4% of oocyte retrievals were day 3 transfers; hence, exposing all oocytes to sperm is recommended.
Read More
Chromosomal abnormalities do not impact ART outcomes
January 4th 2023Chromosomal abnormalities in infertile couples who use assisted reproductive technology (ART) do not appear to impact cumulative clinical pregnancy or live-birth rates, according to a study published in the Annals of Medicine.
Read More
2 Clarke Drive
Cranbury, NJ 08512